Drugs News and Research

RSS

High levels of HDL have been linked to increased breast cancer risks, enhance cancer aggressiveness

High levels of high density lipoprotein (HDL), also known as the "good cholesterol," are thought to protect against heart disease. However, what's good for one disease may not be good for another.

10 Oct 2013

WHO prequalifies affordable vaccine to protect children against Japanese encephalitis

An affordable vaccine to protect children against deadly Japanese encephalitis has been prequalified by the World Health Organization, paving the way to reach millions more children across Asia at risk for the disease.

10 Oct 2013

HMI, NCONN to collaborate on various educational initiatives for oncology health professionals

Haymarket Media Inc. and the National Coalition of Oncology Nurse Navigators have formed a partnership to collaborate on a wide variety of educational initiatives for the oncology health professionals they serve.

9 Oct 2013

First Edition: September 9, 2013

Today's headlines include reports on how some state health online insurance marketplaces are working as well as the latest from Capitol Hill on the budget standoff.

9 Oct 2013

ARIAD announces changes in Iclusig product labeling to reflect updated safety information

ARIAD Pharmaceuticals, Inc. today announced results of its review of updated clinical data from the pivotal PACE trial of Iclusig® (ponatinib) and actions that it is taking following consultations with the U.S. Food and Drug Administration (FDA).

9 Oct 2013

DSP to set up anti-cancer drugs sales company in US

Dainippon Sumitomo Pharma Co., Ltd. (DSP) announced on October 9 that it has decided to establish an anti-cancer drugs sales company in the United States as a wholly-owned subsidiary of DSP's 100% owned U.S. holding company.

9 Oct 2013

Molecular Templates secures $8.5M series C financing plus $10.6M grant from CPRIT

Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of biologic therapeutics, announced today that it recently secured an $8.5M series C financing led by Excel Venture Management. Santé Ventures, an existing investor, also participated in the round.

9 Oct 2013

New combinations of postoperative pain treatment decreased both pain and use of pain relievers

New combinations of postoperative pain treatment decreased both pain and the use of narcotic pain relievers according to two studies presented this week at the 2013 Clinical Congress of the American College of Surgeons.

9 Oct 2013

New method for improving cord blood transplant success

Starting with a discovery in zebrafish in 2007, Harvard Stem Cell Institute researchers have published initial results of a Phase Ib human clinical trial of a therapeutic that has the potential to improve the success of blood stem cell transplantation.

9 Oct 2013

Binge eating disorder is different from anorexia nervosa and bulimia nervosa

Food addiction is not yet recognised as a mental disorder but certain obese individuals clearly display addictive-like behaviour towards food.

9 Oct 2013

Janssen buys all rights from GSK to develop, commercialize hepatitis C compound

Janssen Pharmaceuticals, Inc. announced today the acquisition of the investigational compound GSK2336805, an NS5a replication complex inhibitor in Phase 2 development for the treatment of chronic hepatitis C, from an affiliate of GlaxoSmithKline plc.

9 Oct 2013

Study: Distinct behavior of proteins reflects common biochemical principles

Researchers from Case Western Reserve University School of Medicine have found unexpected similarities between proteins that were thought to be fundamentally different.

9 Oct 2013

New HIV vaccines stimulate critical immune response in infants born to HIV-infected mothers

A new analysis of two HIV vaccine trials that involved pediatric patients shows that the investigational vaccines stimulated a critical immune response in infants born to HIV-infected mothers, researchers at Duke Medicine report.

9 Oct 2013

Study looks at attitudes toward drug use among high school seniors

High school seniors who frown upon the use of drugs are most likely to be female, nonsmokers or hold strong religious beliefs, according to a study- by Joseph Palamar of New York University. Palamar examines how teenagers' attitudes toward marijuana influenced their thoughts on the further use of other illicit drugs.

9 Oct 2013

Cost issues: Expensive patients; payoff from delaying aging; approving new treatments

Cost and quality issues in the news include research about the costliest U.S. patients, the potential that delaying aging instead of treating disease could have on extending life, and examining how the U.S. compares to other countries on approving new medical treatments.

9 Oct 2013

Nuventra launches innovative software platform for conducting population PK analyses

Nuventra Pharma Sciences, a specialty pharmaceutical consulting firm with global reach, is pleased to announce the launch and availability of an innovative software platform called Darwin for conducting population pharmacokinetic (PK) analyses based on a genetic algorithm paradigm.

9 Oct 2013

Report: States lax in taking steps to curb prescription drug abuse

The number of deaths attributed to the abuse of painkillers and other prescription drugs has risen sharply in recent years.

9 Oct 2013

Quintiles and MDA partner to develop U.S. Neuromuscular Disease Registry

Quintiles and the Muscular Dystrophy Association (MDA) today announced a new partnership to develop and implement the U.S. Neuromuscular Disease Registry, a patient registry that will play an important role in determining effective treatments for people with muscular dystrophy and related muscle diseases.

9 Oct 2013

Moximed initiates pivotal trial of KineSpring System implantation in knee osteoarthritis patients

Moximed, Inc. announced today that the KineSpring® System, an implantable medical spring for knee osteoarthritis that works by unloading the weight on the diseased joint, has been successfully implanted in the first patients enrolled in the UK arm of its multi-centre GOAL study.

9 Oct 2013

Alnylam advances Development Candidate for ALN-AS1 for treatment of hepatic porphyrias

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it is advancing its Development Candidate for ALN-AS1, an RNAi therapeutic targeting aminolevulinate synthase-1 (ALAS-1) for the treatment of hepatic porphyrias including acute intermittent porphyria (AIP).

9 Oct 2013

Drugs News and Research

High levels of HDL have been linked to increased breast cancer risks, enhance cancer aggressiveness

WHO prequalifies affordable vaccine to protect children against Japanese encephalitis

HMI, NCONN to collaborate on various educational initiatives for oncology health professionals

First Edition: September 9, 2013

ARIAD announces changes in Iclusig product labeling to reflect updated safety information

DSP to set up anti-cancer drugs sales company in US

Molecular Templates secures $8.5M series C financing plus $10.6M grant from CPRIT

New combinations of postoperative pain treatment decreased both pain and use of pain relievers

New method for improving cord blood transplant success

Binge eating disorder is different from anorexia nervosa and bulimia nervosa

Janssen buys all rights from GSK to develop, commercialize hepatitis C compound

Study: Distinct behavior of proteins reflects common biochemical principles

New HIV vaccines stimulate critical immune response in infants born to HIV-infected mothers

Study looks at attitudes toward drug use among high school seniors

Cost issues: Expensive patients; payoff from delaying aging; approving new treatments

Nuventra launches innovative software platform for conducting population PK analyses

Report: States lax in taking steps to curb prescription drug abuse

Quintiles and MDA partner to develop U.S. Neuromuscular Disease Registry

Moximed initiates pivotal trial of KineSpring System implantation in knee osteoarthritis patients

Alnylam advances Development Candidate for ALN-AS1 for treatment of hepatic porphyrias

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News